Clinical trial registry record

Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Knee Arthroplasty

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 30, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06925880
Last registry update
March 30, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Consorci Sanitari del Maresme
Enrollment
262
Countries
Spain
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
Evidence population
Human clinical study registration
Participants
262
Population
ALL · 65 Years
Duration
2025-06-10 to 2027-10-31
Intervention
Creatine Monohydrate; Placebo
Comparator
PLACEBO
Outcomes measured
Change in muscle mass — Baseline, 3 and 6 months follow-up; Change in Muscle Strenght — Baseline, 3 and 6 months follow-up; Change in the prevalence of Sarcopenia — Baseline, 3 and 6 months follow-up; Change in Functional Capacity — Baseline, 3 and 6 months follow-up; Changes in Performance — Baseline, 3 and 6 months follow-up; Changes in Physical Performance — Baseline, 3 and 6 months follow-up; Changes in aerobic capacity — Baseline, 3 and 6 months follow-up; Changes in Walking Speed — Baseline, 3 and 6 months follow-up; Number of Advers Health Events — Baseline, 3 and 6 months follow-up; Change in Frailty status — Baseline, 3 and 6 months follow-up; Arthroscopy complications — Baseline, 3 and 6 months follow-up
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Creatine and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

creatine aging
Read the original source →Export JSON